Olfactory receptors like Olfr1113, which belong to the GPCR family, play a crucial role in the detection and discrimination of a wide array of odorants. The regulation and inhibition of these receptors, either directly or indirectly, are significant for understanding olfactory processes and potentially modifying them. The chemicals listed serve as potential indirect inhibitors or modulators of Olfr1113 by targeting various aspects of the GPCR signaling pathways and cellular processes. Brefeldin A, by disrupting protein transport, may reduce the presence of Olfr1113 at the cell surface, thus diminishing its functional response to odorants. Genistein and Forskolin affect the phosphorylation status of proteins and levels of cAMP, respectively, both critical in the olfactory GPCR signaling cascade. PD 98059, Wortmannin, LY 294002, U-73122, SB203580, SP600125, Chelerythrine chloride, Gö 6976, and KN-93 are inhibitors that target specific enzymes or signaling molecules like MEK, PI3K, phospholipase C, MAPK, JNK, and protein kinase C. These components are integral to the activation, regulation, and signaling of GPCRs, including olfactory receptors.
The indirect modulation of Olfr1113 via these chemicals can provide insights into the molecular mechanisms governing olfactory perception and aid in the development of strategies for conditions where olfactory function is compromised. However, the broad and varied biological effects of these inhibitors on cellular functions and signaling pathways necessitate careful consideration and a thorough understanding of their mechanisms of action, especially when applied to olfactory research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the transport of proteins in cells, which can affect the trafficking and surface expression of olfactory receptors like Olfr1113. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor and can modulate the phosphorylation of proteins involved in the olfactory signaling pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 inhibits MEK, a part of the MAPK/ERK pathway, which is implicated in the regulation of olfactory receptor function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of PI3K, influencing phosphoinositide signaling that could indirectly affect olfactory receptor functions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002, similar to Wortmannin, is a PI3K inhibitor that plays a role in modulating olfactory receptor signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 inhibits p38 MAPK, which can have implications on the MAPK pathway involved in olfactory signal transduction. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, affecting another component of the MAPK pathway, potentially impacting olfactory receptor signaling. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Chelerythrine chloride is a protein kinase C inhibitor and can alter the signaling pathways linked to olfactory receptor function. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Gö 6976 is a selective protein kinase C inhibitor and may modulate processes affecting olfactory receptors. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 inhibits Ca2+/calmodulin-dependent protein kinase II, which may influence calcium signaling in olfactory neurons. | ||||||